Meningococcal Vaccination
Vaccines help protect against all three serogroups (B, C, and Y) of meningococcal disease commonly seen in the United States:
- Meningococcal conjugate vaccines (Menactra® and Menveo®)
- Serogroup B meningococcal vaccines (Bexsero® and Trumenba®)
What Everyone Should Know about Meningococcal Vaccines
- Who Should Get These Vaccines?
- Who Should Not Get These Vaccines?
- What Types of Vaccines Are There?
- How Well Do These Vaccines Work?
- What Are the Possible Side Effects?
- Where Can I Find These Vaccines?
- How Do I Pay for These Vaccines?
Information on Meningococcal Vaccine Recommendations
In addition to meningococcal conjugate vaccination, clinicians may choose to administer a serogroup B meningococcal vaccine to patients 16 through 23 years old. Get information about these vaccine recommendations.
Meningococcal Vaccination: Information for Healthcare Professionals
- Meningococcal Vaccine Recommendations
- About Meningococcal Vaccines
- Storage and Handling for Meningococcal Vaccines
- Administering Meningococcal Vaccines
- Meningococcal Vaccine Resources
Vaccination Coverage
Related Pages
- Have You Heard About How To Prevent Meningococcal Disease?
View this video on CDC-TV or on YouTube - Meningococcal Vaccine Recommendations of the Advisory Committee on Immunization Practices
- Page last reviewed: March 28, 2017
- Page last updated: March 28, 2017
- Content source:
- Content source: National Center for Immunization and Respiratory Diseases